Journal article
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies
The oncologist (Dayton, Ohio), Vol.25(6), pp.532-540
01/14/2020
DOI: 10.1634/theoncologist.2019-0615
PMCID: PMC7288652
PMID: 31943534
Abstract
This systematic review of pediatric oncology phase I trials describes the safety profile and response outcomes from recent trials, comparing cytotoxic and targeted trials in the era of targeted therapies.
Details
- Title: Subtitle
- A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies
- Creators
- Julia W. Cohen - National Cancer InstituteSrivandana Akshintala - National Cancer InstituteEli Kane - National Cancer InstituteHelen Gnanapragasam - National Cancer InstituteBrigitte C. Widemann - National Cancer InstituteSeth M. Steinberg - National Cancer InstituteNirali N. Shah - National Cancer Institute
- Resource Type
- Journal article
- Publication Details
- The oncologist (Dayton, Ohio), Vol.25(6), pp.532-540
- Publisher
- John Wiley & Sons, Inc
- DOI
- 10.1634/theoncologist.2019-0615
- PMID
- 31943534
- PMCID
- PMC7288652
- ISSN
- 1083-7159
- eISSN
- 1549-490X
- Alternative title
- Systematic Review of Pediatric Oncology Phase I Trials
- Language
- English
- Date published
- 01/14/2020
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984359821502771
Metrics
22 Record Views